Abstract
The genetically mediated difference in aromatic hydrocarbon-inducible hepatic aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity is associated with the metabolic activation of 2-acetylaminofluorene to a mutagen in vitro by liver fractions. With the use of"responsive" C57BL/6N and "nonresponsive" DBA/2N inbred strains and offspring from the appropriate crosses, the aromatic hydrocarbon-inducible hydroxylase activity appears to be expressed as an autosomal dominant trait, whereas 2-acetylaminofluorene mutagenicity in vitro appears to be expressed additively. With N-hydroxy-2-acetylaminofluorene added in vitro, no metabolic activation is necessary for mutagenesis to occur; however, mutagenicity is enhanced 20-40-fold in the presence of liver fractions. The metabolic activation of N-hydroxy-2-acetylaminofluorene to a frameshift mutagen in vitro is not associated with the genetically mediated difference in aromatic hydrocarbon responsiveness. We therefore suggest that the rate-limiting step of 2-acetylaminofluorene mutagenesis is its activation by cytochrome P1450 to the N-hydroxy derivative, which is metabolized further to a much more mutagenic intermediate by a reaction independent of cytochrome P1450-possibly a deacetylation reaction.
ACKNOWLEDGMENT We appreciate very much the expert technical assistance of Roy C. Levitt.
- Copyright © 1976 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|